Core lab reports fourth quarter and full year 2024 results

Fourth quarter revenue of $129.2 million, down 4% sequentially and up slightly year-over-year fourth quarter operating income of $14.2 million; ex-items, $15.7 million, down 14% sequentially, up 4% year-over-year fourth quarter operating margins, ex-items, of 12%  fourth quarter gaap eps of $0.15; ex-items, $0.22, down 12% sequentially, up 16% year-over-year fourth quarter free cash flow of $16.2 million, up over 50% sequentially  debt leverage ratio reduced to 1.31, and net debt reduced by $11.7 million company repurchased 264,982 shares of common stock, a value of $4.9 million, during the fourth quarter company announces q1 2025 quarterly dividend full year revenue of $523.8 million, up 3% full year operating income of $58.6 million; ex-items, $65.3 million, up 7% full year gaap eps of $0.66; ex-items, eps of $0.87, up 9% full year free cash flow of $43.4 million, up over 200% compared to 2023 houston , jan. 29, 2025 /prnewswire/ -- core laboratories inc. (nyse: "clb") ("core", "core lab", or the "company") reported fourth quarter 2024 revenue of $129,200,000. core's operating income was $14,200,000, with diluted earnings per share ("eps") of $0.15, all in accordance with u.s. generally accepted accounting principles ("gaap").
CLB Ratings Summary
CLB Quant Ranking